Industry reports
Editor highlights

Biotechnology Industry Market Research Reports in China, April 2014

You might be interested in: cell therapy, stem cell, protein, more »

» View Public Reports

1-30 of about 200 reports

Biosimilar Market in China

  • Industry report
  • March 2014
  • 6 pages
  • Industries: Biopharmaceutical
  • Countries: China

Company Report: Gmo in Vietnam, China and Singapore for Year 2014

  • Company report
  • February 2014
  • 14 pages
  • Industries: Genetically Modified Organism, Gmo
  • Countries: Vietnam, China, Singapore

The Chinese Genetically Modified Organism, Gmo Business

  • Industry report
  • February 2014
  • 29 pages
  • by Research Paper

... Analysis. The transcriptional levels of mapip1;1 in the 5 independent t3 lines was examined by qrt-pcr analysis, in which the atactin gene was used as an internal control. Drought and salt stress ...

  • Industries: Genetically Modified Organism, Gmo
  • Countries: China

Company Report: Biological Therapy in China for Year 2014

  • Company report
  • January 2014
  • 26 pages
  • by Market Research Publisher
  • Industries: Biological Therapy
  • Countries: China

Company Report: Biological Therapy in China for Year 2013

  • Company report
  • December 2013
  • 56 pages
  • by Market Research Publisher

... Prevalence of stem cell related research and development, scientists from all over the world are stampeding to explore the possibility of transforming the results of research and develop into meaningful ...

  • Industries: Biological Therapy
  • Countries: China

Tianjin TEDA Biomedical Engineering Company Ltd. - Company Report for Year 2013

  • Company report
  • December 2013
  • 98 pages
  • by Market Research Publisher
  • Industries: Fertilizer, Biotechnology
  • Countries: China

Company Report: Biological Therapy in China and The United States for Year 2013

  • Company report
  • December 2013
  • 69 pages

... Was determined to not be needed as the company is still performing clinical trials and has not yet generated revenues from its cell therapy cands in the biomedicine segment. Correspondingly the company has ...

  • Industries: Biological Therapy
  • Countries: China, United States

Company Report: Biological Therapy in The United States and China for Year 2013

  • Company report
  • December 2013
  • 290 pages

... Subsidiary, as discussed in further detail below. We are focused on developing and marketing safe and effective cell-based therapies to treat serious chronic and degenerative diseases including cancer ...

  • Industries: Biological Therapy
  • Countries: United States, China

Company Report: Biological Therapy in China for Year 2013

  • Company report
  • November 2013
  • 6 pages
  • by Market Research Publisher

... And scholars of the university of oxford (the oxford university ) for the sponsorship of a research programme in the field of stem cell therapy and tissue engineering; and (ii) a consultancy agreement ...

  • Industries: Biological Therapy
  • Countries: China

Company Report: Biopharmaceutical in China and New Zealand for Year 2013

  • Company report
  • November 2013
  • 3 pages
  • Industries: Biopharmaceutical
  • Countries: China, New Zealand

Genetically Modified Organism, Gmo Sector in China

  • Industry report
  • November 2013
  • 10 pages

... For cultivation purposes. The pollen is transferred to the female organs manually. Male-sterile plants have been developed both by conventional cultivation procedures as well as by genetic modification ...

  • Industries: Genetically Modified Organism, Gmo
  • Countries: China

Company Report: Biological Therapy in China for Year 2013

  • Company report
  • October 2013
  • 25 pages
  • by Market Research Publisher

... Of stem cell related research and development, scientists from all over the world are stampeding to explore the possibility of transforming the results of these research and development into meaningful ...

  • Industries: Biological Therapy
  • Countries: China

Company Report: Biological Therapy in China for Year 2013

  • Company report
  • October 2013
  • 25 pages

... Of stem cell related research and development, scientists from all over the world are stampeding to explore the possibility of transforming the results of these research and development into meaningful ...

  • Industries: Biological Therapy
  • Countries: China

Company Report: Biological Therapy in China for Year 2013

  • Company report
  • July 2013
  • 26 pages

... With the increasing prevalence of stem cell related research and development, scientists from all over the world are stampeding to explore the possibility of transforming the results of these research ...

  • Industries: Biological Therapy
  • Countries: China

Company Report: Biological Therapy in China for Year 2013

  • Company report
  • July 2013
  • 26 pages
  • by Market Research Publisher
  • Industries: Biological Therapy
  • Countries: China

Company Report: Biological Therapy in China for Year 2013

  • Company report
  • July 2013
  • 26 pages
  • by Market Research Publisher

... With the increasing prevalence of stem cell related research and development, scientists from all over the world are stampeding to explore the possibility of transforming the results of these research ...

  • Industries: Biological Therapy
  • Countries: China

Biopharmaceutical Key Market Figures in China

  • Industry report
  • July 2013
  • 16 pages

... Of funding opportunities to chinese companies conducting innovative biologic drug r&d ---------------------------------- 81 2.4.4 Fast enriching innovative biologic drug pipeline of chinese ...

  • Industries: Biopharmaceutical
  • Countries: China

Company Report: Biotechnology in Japan and China for Year 2013

  • Company report
  • May 2013
  • 54 pages
  • Industries: Biotechnology
  • Countries: Japan, China

The Chinese Biotechnology Business Brief

  • Industry report
  • May 2013
  • 21 pages

... Chi n a s ta n d a rd t im e p rin te d mckinsey & company | 15 20+ regional life-science or biotech industry parks have been set up chengdu tcm innovative drugs biomedical engineering ...

  • Industries: Biotechnology
  • Countries: China

Company Report: Biological Therapy in China for Year 2013

  • Company report
  • March 2013
  • 32 pages
  • by Market Research Publisher
  • Industries: Biological Therapy
  • Countries: China

Stl Television Ltd. - Company Report for Year 2013

  • Company report
  • March 2013
  • 151 pages
  • Industries: Biological Therapy
  • Countries: China

Tianjin TEDA Biomedical Engineering Company Ltd. - Company Report for Year 2013

  • Company report
  • March 2013
  • 2 pages
  • by Market Research Publisher

... Of the company and potential investors are advised to exercise caution when dealing in the shares of the company. By order of the board tianjin teda biomedical engineering company limited wang shuxin chairman ...

  • Industries: Biotechnology
  • Countries: China

Stl Television Ltd. - Company Report for Year 2013

  • Company report
  • March 2013
  • 151 pages
  • by Market Research Publisher

... Have been utilized for the investment in the stem cell business and general working capital of the group. We consider that the placing can strengthen the capital base of the company and enhance ...

  • Industries: Biological Therapy
  • Countries: China

Stl Television Ltd. - Company Report for Year 2013

  • Company report
  • March 2013
  • 151 pages
  • by Market Research Publisher

... At approximately us$15 billion, and growing in double digits on an annual basis. We believe the stem cell technology business provide good opportunities for the group to diversify from the existing business ...

  • Industries: Biological Therapy
  • Countries: China

INTREXON Corp. - Investment Analysis, March 2013

  • Company report
  • March 2013
  • 10 pages

... For laviv and for pivotal studies of azficel-t cells for medical applications. The research, which has focused on improving the culture media, has already increased the proliferation rate by as much ...

  • Industries: Biological Therapy
  • Countries: China

Investor presentation: Genomics in Australia and China for Year 2013

  • Company report
  • March 2013
  • 25 pages
  • Industries: Genomics
  • Countries: Australia, World, China

Company Report: Biopharmaceutical in China for Year 2013

  • Company report
  • March 2013
  • 5 pages
  • Industries: Biopharmaceutical
  • Countries: China

Company Report: Biopharmaceutical in China and The United States for Year 2013

  • Company report
  • March 2013
  • 6 pages

... Predictively as a companion diagnostic agent for antibodies with the caix target molecule. Wilex ag will participate in any future marketing of this test and other biomarker tests by means of percentage ...

  • Industries: Biopharmaceutical
  • Countries: China, United States

Agriculture Gmo Business in India, Kenya and China

  • Industry report
  • February 2013
  • 25 pages

... Such as via campesina, the food sovereignty movement, the un special rapporteur on the right to food and pingos in both the south and the north. The attempt to persuade udcs to accept and adopt gm foods ...

  • Industries: Genetically Modified Organism, Gmo
  • Countries: India, Kenya, China

Company Report: Cell Therapy in China and The United States for Year 2013

  • Company report
  • February 2013
  • 26 pages

... Rights reserved. 6 2/19/13 6 Regulation autologous cell therapies are regulated as medical technology duplication technology that has already passed phase ii clinical trials with us fda has ...

  • Industries: Biological Therapy
  • Countries: China, United States

» Purchase Premium Reports (From $ 30 - $ 4 650)

About 100 reports
Alcohol and Starch/Sugar Enzyme Market by Type (Carbohydrase, Protease, and Lipase), by Application (Industrial, Specialty) & Geography - Global Trends & Forecasts to 2018

Alcohol and Starch/Sugar Enzyme Market by Type (Carbohydrase, Protease, and Lipase), by Application (Industrial, Specialty) & Geography - Global Trends & Forecasts to 2018

  • $ 4 650
  • Industry report
  • March 2014
  • by MarketsandMarkets

Alcohol enzymes are extensively used in various industrial applications that incorporate the production of food and beverages, biofuels, cleaning agents, and others. Due to their versatile applications, ...

Biomaterials China News 1403

March 2014 $ 3 463

Sports Nutrition In China

March 2014 $ 898

Biotech Market In China - 2014

January 2014 $ 500

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.